DE60120357D1 - Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff - Google Patents

Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff

Info

Publication number
DE60120357D1
DE60120357D1 DE60120357T DE60120357T DE60120357D1 DE 60120357 D1 DE60120357 D1 DE 60120357D1 DE 60120357 T DE60120357 T DE 60120357T DE 60120357 T DE60120357 T DE 60120357T DE 60120357 D1 DE60120357 D1 DE 60120357D1
Authority
DE
Germany
Prior art keywords
outer membrane
impf
membrane protein
haemophilus influenza
influenza outer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60120357T
Other languages
English (en)
Other versions
DE60120357T2 (de
Inventor
Francois-Xavier Jacque Berthet
Philippe Denoel
Jan Poolman
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of DE60120357D1 publication Critical patent/DE60120357D1/de
Application granted granted Critical
Publication of DE60120357T2 publication Critical patent/DE60120357T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60120357T 2000-02-15 2001-02-13 Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff Expired - Lifetime DE60120357T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0003502 2000-02-15
GBGB0003502.2A GB0003502D0 (en) 2000-02-15 2000-02-15 Vaccine
PCT/EP2001/001556 WO2001061013A1 (en) 2000-02-15 2001-02-13 Haemophilus influenza outer membrane protein and use thereof in vaccination

Publications (2)

Publication Number Publication Date
DE60120357D1 true DE60120357D1 (de) 2006-07-20
DE60120357T2 DE60120357T2 (de) 2007-06-06

Family

ID=9885665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60120357T Expired - Lifetime DE60120357T2 (de) 2000-02-15 2001-02-13 Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff

Country Status (10)

Country Link
US (3) US20030096370A1 (de)
EP (1) EP1254234B1 (de)
JP (1) JP4815090B2 (de)
AT (1) ATE329032T1 (de)
AU (1) AU2001239262A1 (de)
CA (1) CA2399480C (de)
DE (1) DE60120357T2 (de)
ES (1) ES2264438T3 (de)
GB (1) GB0003502D0 (de)
WO (1) WO2001061013A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
AU2006277076B2 (en) 2005-08-10 2012-03-29 Arne Forsgren Ab Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
CN104436180B (zh) 2006-01-17 2021-08-31 阿恩·福斯格伦 新的表面外露流感嗜血菌蛋白质(蛋白质E;pE)
US8617574B2 (en) 2009-02-13 2013-12-31 Valneva Austria Gmbh Nontypable Haemophilus influenzae antigens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine

Also Published As

Publication number Publication date
EP1254234A1 (de) 2002-11-06
ATE329032T1 (de) 2006-06-15
EP1254234B1 (de) 2006-06-07
CA2399480C (en) 2011-11-15
US20090175912A1 (en) 2009-07-09
CA2399480A1 (en) 2001-08-23
ES2264438T3 (es) 2007-01-01
WO2001061013A1 (en) 2001-08-23
AU2001239262A1 (en) 2001-08-27
JP4815090B2 (ja) 2011-11-16
JP2003522543A (ja) 2003-07-29
US20030096370A1 (en) 2003-05-22
DE60120357T2 (de) 2007-06-06
US7811590B2 (en) 2010-10-12
US20060251671A1 (en) 2006-11-09
GB0003502D0 (en) 2000-04-05

Similar Documents

Publication Publication Date Title
AP2001002199A0 (en) Novel streptococcus antigens
EA200201280A1 (ru) Стрептококковые антигены
DK1645631T3 (da) Neisseria antigener og præparater
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
AP2000001886A0 (en) Group B streptococcus antigens.
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
BR0010720A (pt) Peptìdeos de neisseria antigênicos
NO20006191L (no) Vaksine
DE69533544D1 (de) Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
WO2004006952A3 (en) Therapeutic tuberculosis vaccines
DE60039050D1 (de) Antigene meningokokken peptide
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
ATE323164T1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
DE60118359D1 (de) Humanische pellino-polypeptide
DE60120357D1 (de) Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
DK0680765T3 (da) Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
DE60037413D1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
ATE338063T1 (de) Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers

Legal Events

Date Code Title Description
8364 No opposition during term of opposition